MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Low Nutritional and Metabolic Abnormalities Predict the Incidence of Parkinson Diseases: A Large Prospective Cohort Study

    J. Fu, X. Chen, H. Shang (Chengdu, China)

    Objective: This study aimed to comprehensively analyze the temporal changes in body composition and blood nutritional metabolic biomarkers before the onset of Parkinson disease (PD)…
  • 2025 International Congress

    Facilitators and Barriers to Exercise Program Implementation in Parkinson’s Disease Rehabilitation: A Comprehensive Review Using the Consolidated Framework for Implementation Research

    M. M. Elsayed, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. Mohamed, A. Nagah (Mansoura, Egypt)

    Objective: To systematically identify and evaluate the facilitators and barriers influencing the implementation of exercise programs in Parkinson’s disease (PD) rehabilitation using the Consolidated Framework…
  • 2025 International Congress

    Unraveling Parkinson’s Disease Heterogeneity: Variability in Dopaminergic Medication Response Over Five Years – A Cluster Analysis of PPMI Data

    N. Rajabli, M. Vakhshoori, A. Espay, J. Jones, A. Baghaei, K. Dashtipour (Loma Linda, USA)

    Objective: We sought to examine which demographic, genetic, and clinical characteristics inParkinson’s disease (PD) are associated with differences in levodopa equivalent daily dose(LEDD) at five…
  • 2025 International Congress

    Educational Strategies for Enhancing Caregiver Knowledge and Capacities in Parkinson’s Disease Management: A Comprehensive Review

    S. A. Hassan, S. Abozeid, Y. M.HUSSEINY, H. Abdelbar, S. Elrobeigi, M. M. Elsayed (Giza, Egypt)

    Objective: To evaluate the effectiveness of educational strategies in enhancing caregiver knowledge, skills, and confidence in managing Parkinson’s disease (PD) and to identify gaps in…
  • 2025 International Congress

    Assessing the Impact of Interprofessional Education on Collaborative Practice in Neurorehabilitation for Parkinson’s Disease: A Systematic Review

    Y. Hamdi, S. Elsenbawy, G. Abozeid, D. W. Ismail, H. Elshazly, M. Elsayed (Giza, Egypt)

    Objective: To evaluate the effectiveness of interprofessional education (IPE) in enhancing collaborative practice among healthcare professionals involved in neurorehabilitation for Parkinson’s disease (PD) Background: PD…
  • 2025 International Congress

    Demographic Characteristics of Women with Primary Parkinsonism

    E. Tharp, J. Martinez-Lemus, J. Suescun, M. Schiess (Houston, USA)

    Objective: To assess the demographic profile and other health characteristics of women with primary parkinsonism who present to the Texas Medical Center for care. Background:…
  • 2025 International Congress

    Risk factors in a population with high prevalence of Parkinson’s disease in Chile

    ME. Contreras Pinto, U. Hernandez Villarroel, N. Angel, F. Pancetti Vaccari, B. Soto, M. Ramirez, M. Vera Amoroso, J. Otero Olmos, G. Oneto Diaz, C. Morales (la serena, Chile)

    Objective: The aim of this study was to investigate the frequency of environmental risk factors, comorbidities and family history in a population with Pakinson disease…
  • 2025 International Congress

    Perceived Versus Actual Performance During Dual-Task Walking: Insights from Parkinson’s Disease

    H. Johansson, B. Leavy (Stockholm, Sweden)

    Objective: To explore the concordance between perceived difficulty and focus, to actual performance during a dual-task (DT) two-minute walk test (2MWT) in people with Parkinson’s…
  • 2025 International Congress

    Clinical Manifestations and Rate of Progression of Parkinsons Disease in Different Regions

    M. Qurbonova, M. Isrofilov (Dushanbe, Tajikistan)

    Objective: To determine the differences in the age of onset of clinical manifestations and rate of progression of Parkinson's disease in different regions of Tajikistan.…
  • 2025 International Congress

    Alpha-Synuclein Accumulation-Attenuating Effect of Brain-Derived Neurotrophic Factor in Primary Cell Culture Model of Parkinson’s Disease

    I. Hlushchuk, MT. Airavaara (Helsinki, Finland)

    Objective: To explore the role of neurotrophic signaling pathways in modulating the effect of brain-derived neurotrophic factor (BDNF) on pre-formed fibrils (PFFs)- induced alpha-synuclein (aSyn)…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley